Metastatic Breast Cancer Clinical Trials in Amsterdam, North Holland
2 recruitingAmsterdam, North Holland, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Phase 2
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
Metastatic Breast Cancer
The Netherlands Cancer Institute60 enrolled1 locationNCT06342037